These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10670029)

  • 21. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
    Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G
    Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of p53 and proliferating cell nuclear antigen in malignant tumor of maxillary sinus].
    Xie RH; Chen ZH; Chen MY; Hou JH; Wu JH; Wu GH; Wu QL
    Ai Zheng; 2002 Nov; 21(11):1244-7. PubMed ID: 12526226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of PCNA, Ki67 and p53 in nasal polyposis and sinonasal inverted papillomas.
    Mumbuc S; Karakok M; Baglam T; Karatas E; Durucu C; Kibar Y
    J Int Med Res; 2007; 35(2):237-41. PubMed ID: 17542411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
    Dang CX; Han Y; Qin ZY; Wang YJ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of cell proliferation and apoptosis gene associated protein on nasal polyps and its significance].
    Dong Z; Guan G; Chang W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):429-31. PubMed ID: 12768752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
    Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
    Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some oncogene and tumour suppressor gene protein products expression in B-cell chronic lymphocytic leukaemia.
    Niewiadomska H; Mirowski M; Kulczycka D; Najder M; Balcerczak E; Błoński JZ
    Cytobios; 2000; 103(404):159-68. PubMed ID: 11086711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric DNA analysis, and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: preliminary results.
    Bektas A; Yasa MH; Kuzu I; Dogan I; Unal S; Ormeci N
    Hepatogastroenterology; 2001; 48(38):408-12. PubMed ID: 11379319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
    Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of p53, PCNA expression and trace element content in esophageal mucosa].
    Zhao WX; Shi TX; Gao XP; Zhang HX; Li SL
    Ai Zheng; 2002 Jul; 21(7):757-60. PubMed ID: 12479101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of cancer cell growth and apoptosis in morphogenesis of colorectal cancer].
    Seki H
    Hokkaido Igaku Zasshi; 2000 Sep; 75(5):325-34. PubMed ID: 11070793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
    Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.
    Mäkinen K; Loimas S; Hakala T; Eskelinen M
    Anticancer Res; 2007; 27(1A):23-6. PubMed ID: 17352211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
    Niu Y; Wang H; Ji J; Lin H; Zhang A
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.